title: Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience.
authors.affiliation: a Catholic University of the Sacred Heart , Rome , Italy ;
authors.forename: Luca
authors.initials: L
authors.lastname: Laurenti
authors.affiliation: a Catholic University of the Sacred Heart , Rome , Italy ;
authors.forename: Francesco
authors.initials: F
authors.lastname: Autore
authors.affiliation: a Catholic University of the Sacred Heart , Rome , Italy ;
authors.forename: Idanna
authors.initials: I
authors.lastname: Innocenti
authors.affiliation: b IRCCS Centro Di Riferimento Oncologico Della Basilicata , Rionero in Vulture , Italy ;
authors.forename: Giovanni
authors.initials: G
authors.lastname: D'Arena
authors.affiliation: c Division of Hematology, Department of Molecular Biotechnology and Health Sciences , University of Torino , Torino , Italy ;
authors.forename: Marta
authors.initials: M
authors.lastname: Coscia
authors.affiliation: d Department of Human Pathology , University of Messina , Messina , Italy ;
authors.forename: Patrizia
authors.initials: P
authors.lastname: Mondello
authors.affiliation: a Catholic University of the Sacred Heart , Rome , Italy ;
authors.forename: Patrizia
authors.initials: P
authors.lastname: Chiusolo
authors.affiliation: a Catholic University of the Sacred Heart , Rome , Italy ;
authors.forename: Silvia
authors.initials: S
authors.lastname: Bellesi
authors.affiliation: e International Center for Genetic Engineering & Biotechnology , Monterotondo Scalo , Italy ;
authors.forename: Dimitar G
authors.initials: DG
authors.lastname: Efremov
authors.affiliation: a Catholic University of the Sacred Heart , Rome , Italy ;
authors.forename: Simona
authors.initials: S
authors.lastname: Sica
authors.affiliation: f Department of Cellular Biotechnologies and Hematology , Sapienza University , Rome , Italy.
authors.forename: Francesca Romana
authors.initials: FR
authors.lastname: Mauro
mesh_terms: D000368:Aged; D000744:Anemia, Hemolytic, Autoimmune / Q000139:chemically induced* / Q000453:epidemiology*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000069461:Bendamustine Hydrochloride / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D015994:Incidence; D007558:Italy / Q000453:epidemiology; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy* / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D020360:Neoadjuvant Therapy; D012189:Retrospective Studies; D000069283:Rituximab / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D000069283:Rituximab; D000069461:Bendamustine Hydrochloride